Neuroleptics Flashcards
Alpha-methyltyrosine
Inhibits dopamine synthesis
Reserpine
Interferes with vesicular storage of dopamine
Bromocriptine
D2 agonist
Overcomes the D2 receptor blockade by neuroleptic D2 antagonist drugs
Clinical treatment for Malignant Neuroleptic Syndrome
Diazepam & Dantrolene
Clinical treatment for malignant neuroleptic syndrome
Administered to counteract muscular rigidity of the syndome.
Chlorpromazine
D2 receptor antagonist - prototype drug - typical neuroleptic
Treatment for schizophrenia and bipolar disorder
Side Effects: Parkinsonism, Akathisia (uncontrolled restlessness), Dystonia/Dyskinesia (movement dysfunction), Tardive Dyskinesia (involuntary repetitive body movements), Malignant neuroleptic syndrome. Endocrine effects (hyperprolactinaemia, metabolic syndrome)
Fluphenazine
D2 receptor antagonist - typical neuroleptic
Also has action at muscarinic, alpha-1, H1 & 5-HT2a receptors (small action)
Treatment for schizophrenia and bipolar disorder
Side Effects: Parkinsonism, Akathisia (uncontrolled restlessness), Dystonia/Dyskinesia (movement dysfunction), Tardive Dyskinesia (involuntary repetitive body movements), Malignant neuroleptic syndrome. Endocrine effects (hyperprolactinaemia, metabolic syndrome)
Haloperidol
D2 receptor antagonist - typical neuroleptic
Treatment for schizophrenia and bipolar disorder
Side Effects: Parkinsonism, Akathisia (uncontrolled restlessness), Dystonia/Dyskinesia (movement dysfunction), Tardive Dyskinesia (involuntary repetitive body movements), Malignant neuroleptic syndrome. Endocrine effects (hyperprolactinaemia, metabolic syndrome)
Clozapine
Atypical neuroleptic
Order of affinity:-
- alpha-1 receptor antagonism
- 5-HT2a receptor antagonism
- D1 & D2 receptor antagonism (weak affinity)
High risk of seizures, WBC needs monitoring as can induce agranulocytosis (severe and dangerous leukopenia)
Risperidone
Atypical neuroleptic
- 5-HT receptors (highest affinity)
- D2 receptors
Aripiprazole
Atypical neuroleptic
D2 partial agonist
Complete block of 5HT2c and 5HT1a receptors
Less motor side effects than other neuroleptics
Unlikely to cause metabolic syndrome see in typical neuroleptics.